FDA Approves Levemir® for Women with Diabetes; Keryx Announces Top-Line Data from the Perifosine
By Patrick Crutcher | |
BioMed Reports |
Below is a look at some of the headlines for companies that made news in the healthcare sector on
The label update makes Levemir® the first and only basal insulin analog to have this classification. Until this decision, NPH (human insulin) was considered the standard of care for diabetes in pregnancy. Now,
The
"We are excited that the
In the U.S., there are approximately 1.85 million women of child-bearing age with diabetes. For those who want to get pregnant, this development gives them another option to manage their diabetes.
=====
This Phase 3 trial was conducted pursuant to a Special Protocol Assessment (SPA) agreement with the
Also Monday:
Merck (NYSE:MRK), known as MSD outside
Copyright: | 2012 BioMed Reports All rights reserved. |
Wordcount: | 1301 |
A.M. Best Upgrades Ratings of Pacific International Insurance Limited
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News